203 related articles for article (PubMed ID: 33277980)
1. Pharmacokinetics and Safety of Fosaprepitant Dimeglumine in Healthy Chinese Volunteers: Bioequivalence Study.
Lu K; Lin S; Wang Y; Hao R; Fang L; Zhu J; Zhao D; Yu J; Tong S; Wu Y; Si Y; Ye T; Yang Q; Wang Y
Clin Pharmacol Drug Dev; 2021 Jul; 10(7):748-755. PubMed ID: 33277980
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation.
Ottoboni T; Keller MR; Cravets M; Clendeninn N; Quart B
Drug Des Devel Ther; 2018; 12():429-435. PubMed ID: 29535504
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects.
Lasseter KC; Gambale J; Jin B; Bergman A; Constanzer M; Dru J; Han TH; Majumdar A; Evans JK; Murphy MG
J Clin Pharmacol; 2007 Jul; 47(7):834-40. PubMed ID: 17525168
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Pharmacokinetics and Safety With Bioequivalence of Voriconazole Injection of 2 Formulations in Chinese Healthy Volunteers: Bioequivalence Study.
Huang C; Dong D; Yu F; Ren X; Wu Y; Wang Z; Wang Y
Clin Pharmacol Drug Dev; 2023 May; 12(5):542-547. PubMed ID: 36785899
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers.
Zhu Y; Zhang Q; Zou J; Wan M; Zhao Z; Zhu J
Drug Des Devel Ther; 2015; 9():4621-9. PubMed ID: 26316701
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence study of two digoxin formulations after single-dose administration in healthy Chinese male volunteers.
Zhang XY; Tian Y; Zhang ZJ; Rui JZ; Cao XM
Arzneimittelforschung; 2011; 61(11):601-4. PubMed ID: 22232847
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of a Generic Nateglinide Formulation in Healthy Chinese Volunteers under Fasting and Fed Conditions: A Randomized, Open-Label, Double-Cycle, Double-Crossover Study.
Yu M; Li X; Jin H; Chen L; Wang N; Wang H; Cao Y; Sui X; Gao X; Yang H; Wang W
Pharmacology; 2021; 106(7-8):418-425. PubMed ID: 33866315
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of 2 orodispersible formulations of ondansetron 8 mg in healthy volunteers.
Cánovas M; Rios J; Domenech G; Cebrecos J; Pelagio P; Canals M; Polonio F; Cabré F
Arzneimittelforschung; 2012 Feb; 62(2):59-62. PubMed ID: 22344549
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
17. Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects.
Ottoboni T; Lauw M; Keller MR; Cravets M; Manhard K; Clendeninn N; Quart B
Future Oncol; 2018 Nov; 14(27):2849-2859. PubMed ID: 29873529
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
Zhang Q; Tao Y; Zhu Y; Zhu D
Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
[TBL] [Abstract][Full Text] [Related]
19. A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects.
Shadle CR; Murphy MG; Liu Y; Ho M; Tatosian D; Li SX; Blum RA
Clin Pharmacol Drug Dev; 2012 Jul; 1(3):93-101. PubMed ID: 27121336
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
